Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.typeArtigo de periódicopt_BR
dc.title[drug-delivery Systems For Racemic Bupivacaine (s50-r50) And Bupivacaine Enantiomeric Mixture (s75-r25): Cyclodextrins Complexation Effects On Sciatic Nerve Blockade In Mice].pt_BR
dc.contributor.authorAraújo, Daniele Ribeiro dept_BR
dc.contributor.authorFraceto, Leonardo Fernandespt_BR
dc.contributor.authorBraga, Angélica de Fátima de Assunçãopt_BR
dc.contributor.authorPaula, Eneida dept_BR
unicamp.authorDaniele Ribeiro de Araújo, UNICAMP, Brazil. Fernandes Fraceto,ptélica de Fátima de Assunção Braga,pt de Paula,pt
dc.description.abstractBupivacaine-induced side effects have led to the search for new local anesthetics (LA) with similar potency and lower toxicity, such as bupivacaine enantiomeric mixture (S75-R25). Drug-delivery systems for LA in carriers, such as cyclodextrins (CD), have been developed to improve anesthetic potency and therapeutic index of those drugs. This study aimed at preparing, characterizing and evaluating the anesthetic efficacy of inclusion complexes of bupivacaine enantiomeric mixture (S75-R25) and racemic bupivacaine (S50-R50) with hydroxypropylb- cyclodextrin (HPb-CD) comparing them to clinically available preparations. Inclusion complexes were obtained by mixing appropriate volumes of HPb-CD and S50-R50 or S75-R25 to final 1:1 or 1:2 molar ratios and were characterized by phase solubility experiments. Affinity constants (K) were determined between HPb-CD and each LA. Motor and sensory blocks induced by plain or complexed LA formulations were evaluated in mice by sciatic nerve block. Three LA concentrations were used during the experiment: 0.125, 0.25 and 0.5%. Solubility experiments results were indicative of S50-R50:HPb-CD and S75-R25:HPb-CD complexation, with similar affinity constant (K) values: 14.7 M-1 and 14,3 M-1, respectively. In vivo experiments have shown that complexation has enhanced differential nerve blockade induced by LA: i) motor blockade duration induced by S75-R25 was similar, to the induced by but less intense S50-R50 ( p < 0.001). S50-R50HPb-CD and S75-R25HPb-CD complexes have decreased onset (p < 0.01 and p < 0.05, respectively), without changing motor block intensity (Emax) as compared to plain drugs; ii) sensory block evaluation has revealed higher analgesic intensity with S50-R50HPb-CD (2-fold, p < 0.001) and S75-R25HPb-CD (1.5-1.8-fold, p < 0.01 and p < 0.001, respectively) with both molar ratios (1:1 and 1:2, LA:CD), in addition to prolonging analgesic effect as compared to S50-R50 and S75-R25. More pronounced analgesic effects obtained by complexation with HPb-CD have shown that both formulations, S50-R50HPb-CD and S75-R25HPb-CD, are very useful for postoperative pain relief, requiring lower LA concentrations. Nevertheless, it is worth noticing that S75-R25 - being less toxic than racemic bupivacaine - is an interesting alternative for the development of more effective and safe drug-delivery systems as compared to racemic bupivacaine (S50-R50).en
dc.relation.ispartofRevista Brasileira De Anestesiologiapt_BR
dc.relation.ispartofabbreviationRev Bras Anestesiolpt_BR
dc.identifier.citationRevista Brasileira De Anestesiologia. v. 55, n. 3, p. 316-28, 2005-Jun.pt_BR
dc.description.provenanceMade available in DSpace on 2015-11-27T13:02:45Z (GMT). No. of bitstreams: 2 pmed_19471836por.pdf: 196548 bytes, checksum: 455ed72bb97359a46873fac3c88d816e (MD5) pmed_19471836eng.pdf: 196548 bytes, checksum: 455ed72bb97359a46873fac3c88d816e (MD5) Previous issue date: 2005en
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
pmed_19471836por.pdf191.94 kBAdobe PDFView/Open
pmed_19471836eng.pdf191.94 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.